amaryl 4 mg 30 tabs

Amaryl tablets are used to control blood sugar levels in type 2 diabetes patients and contain glimepiride, which stimulates natural insulin secretion from the pancreas.

What are the ingredients of Amaryl?

Amaryl consists of the following components:

• Active ingredient: Glimepiride.
• It also contains a group of inactive substances that help form the tablet and improve the absorption of the medication in the body.

What are the uses of Amaryl?

It is used to treat the following conditions:

• Type 2 diabetes that does not require insulin.
• Regulating blood sugar levels.
• Reducing the risk of complications caused by chronic high blood sugar.

What are the doses of Amaryl?

The doctor determines the appropriate dose based on each individual case, and it usually includes the following:

• Starting dose: 1 to 2 milligrams once daily with breakfast or immediately after.
• The dose may be gradually increased by 1 to 2 milligrams every week or two depending on the body's response.
• Maximum dose: 8 milligrams per day.
• In cases of kidney or liver disease or in elderly patients: the dose starts at 1 milligram and is adjusted as needed.

Author Name: Pharmacist Nada Mohamed Mostafa

Scientific Degree: Pharmacist

Country: Egypt

Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

Published Date: 17 September 2025